標(biāo)題: Titlebook: Current Management of Melanoma; Ferdinando Cafiero,Franco De Cian Book 2021 Springer Nature Switzerland AG 2021 surgery treatment.sentinel [打印本頁(yè)] 作者: fungus 時(shí)間: 2025-3-21 18:17
書(shū)目名稱Current Management of Melanoma影響因子(影響力)
書(shū)目名稱Current Management of Melanoma影響因子(影響力)學(xué)科排名
書(shū)目名稱Current Management of Melanoma網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Current Management of Melanoma網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Current Management of Melanoma被引頻次
書(shū)目名稱Current Management of Melanoma被引頻次學(xué)科排名
書(shū)目名稱Current Management of Melanoma年度引用
書(shū)目名稱Current Management of Melanoma年度引用學(xué)科排名
書(shū)目名稱Current Management of Melanoma讀者反饋
書(shū)目名稱Current Management of Melanoma讀者反饋學(xué)科排名
作者: 駭人 時(shí)間: 2025-3-21 21:09 作者: 憲法沒(méi)有 時(shí)間: 2025-3-22 02:27 作者: Gleason-score 時(shí)間: 2025-3-22 06:03
Management and Prevention of Lymphatic Complications of Radical Dissections,y cases, sclerosing agents can be used or fibrin glue or other synthetic adhesives can be injected. If conservative treatment fails, surgical treatment can be performed. For what concerns lymphedema, non-operative techniques make it possible to control the evolution of the pathology and reduce the s作者: pellagra 時(shí)間: 2025-3-22 09:24 作者: cogent 時(shí)間: 2025-3-22 15:17
,Erratum to: Wittgenstein’s Investigations,c disease. For higher-risk patients, careful observation may be considered only after a through discussion with the patients about the potential risks and benefits of foregoing CLND. After axillary lymph node dissection, the most common complications are: seromas, wound infections, severe nerve dysf作者: cogent 時(shí)間: 2025-3-22 19:22 作者: Halfhearted 時(shí)間: 2025-3-22 21:15
Slips of Paper and Performance Arts and benefits of CLND. Surgical complications, such as wound healing problems with consequent infection, hematoma, nerve injury, or Frey syndrome may occur. Locoregional recurrence is generally the result of incomplete nodal dissection or uncontrolled soft tissue disease and should be managed by su作者: tympanometry 時(shí)間: 2025-3-23 03:46 作者: infringe 時(shí)間: 2025-3-23 09:07 作者: epinephrine 時(shí)間: 2025-3-23 12:04
2280-9848 professionals involved in melanoma treatment, such as general surgeons, surgical oncologists, medical oncologists, dermatologists, radiotherapists,?and nuclear medicine physicians..978-3-030-45346-6978-3-030-45347-3Series ISSN 2280-9848 Series E-ISSN 2281-0854 作者: regale 時(shí)間: 2025-3-23 17:46 作者: 白楊魚(yú) 時(shí)間: 2025-3-23 18:57
Epidemiology, Prevention and Clinical Diagnosis of Melanoma,inical and dermoscopic features and is a cornerstone of the management of melanoma. Indeed, thin melanomas show a good prognosis whereas thick melanomas are associated with a significant risk of spread and high mortality rates.作者: Neutropenia 時(shí)間: 2025-3-23 23:01
Treatment of Primary Melanoma,including dermis down to the subcutaneous tissue. An incisional biopsy may be needed in aesthetic/functional areas or when dealing with particularly widespread primary lesions. Wide local excision after histological diagnosis is related to the characteristics of the primary lesion (Breslow’s depth) 作者: 縱火 時(shí)間: 2025-3-24 02:52 作者: reptile 時(shí)間: 2025-3-24 06:51
Molecular Assessment in Patients with Melanoma: When and Why?,py dramatically improved the outcomes both in the advanced and metastatic setting. Detection of . mutations has therefore become mandatory to treat patients with advanced or resected high-risk melanoma..In this chapter, we report on the main advantages and disadvantages of the most commonly used dia作者: cathartic 時(shí)間: 2025-3-24 10:47
New Melanoma Staging: Prognostic Factors,e new eighth edition of the AJCC (American Joint Committee on Cancer) melanoma staging system was introduced into clinical practice on January 1st, 2018, bringing many changes in every disease stage compared with the seventh edition (introduced in 2009 and implemented in 2010)..In this chapter, we r作者: POWER 時(shí)間: 2025-3-24 17:38 作者: 入伍儀式 時(shí)間: 2025-3-24 21:52 作者: 大洪水 時(shí)間: 2025-3-25 01:58 作者: 疲憊的老馬 時(shí)間: 2025-3-25 05:38
Surgical Technique and Indications for Radical Dissection: Axilla,ndicated for patients with histo- and/or cytologically proven lymph node metastases and has also an important role in patients’ staging. Lymph node involvement is diagnosed in different ways, most frequently after sentinel lymph node biopsy (SLNB) but a proportion of patients may present clinical ev作者: 敏捷 時(shí)間: 2025-3-25 09:32
Surgical Technique and Indications of Radical Dissection: Groin,emities or lower part of the trunk. The reasons for recommending a complete lymph node dissection (CLND) are the probability of removing residual non-sentinel lymph nodes (NSLN), the prognostic value of NSLN, the better regional control after CLND, the lower morbidity of CLND vs. therapeutic lymph n作者: Instantaneous 時(shí)間: 2025-3-25 15:33 作者: Epidural-Space 時(shí)間: 2025-3-25 16:05
Management and Prevention of Lymphatic Complications of Radical Dissections,mphocele, hematomas and lymphedema. Secondary lymphedema of the limbs is a debilitating and progressive condition that commonly occurs following melanoma treatment. The technique known as lymphatic microsurgical preventive healing approach (LYMPHA) is able to prevent secondary lymphedema following l作者: 流浪者 時(shí)間: 2025-3-25 22:33 作者: 消耗 時(shí)間: 2025-3-26 01:23
Role of Surgery for Metastatic Melanoma, increase in surgical indications also for patients with metastatic melanoma. The surgical indications in this disease setting can be summarized as: collection of biological material; treatment of oligometastatic disease; treatment beyond progression; palliation surgery. In selected cases, surgical 作者: Arrhythmia 時(shí)間: 2025-3-26 05:31 作者: integrated 時(shí)間: 2025-3-26 10:37 作者: OUTRE 時(shí)間: 2025-3-26 14:59
The Management of Melanoma Brain Metastases,totoxic T lymphocyte antigen-4 (CTLA-4) and the programmed cell death protein 1 (PD-1)—has achieved extraordinary response and survival rates in patients with melanoma brain metastases (MBM). On the other hand, also local therapies, especially radiotherapy with the development of less toxic advanced作者: 灌輸 時(shí)間: 2025-3-26 17:23 作者: 珊瑚 時(shí)間: 2025-3-27 00:06 作者: GUILE 時(shí)間: 2025-3-27 01:45
Women Leaders in Chaotic Environmentsincluding dermis down to the subcutaneous tissue. An incisional biopsy may be needed in aesthetic/functional areas or when dealing with particularly widespread primary lesions. Wide local excision after histological diagnosis is related to the characteristics of the primary lesion (Breslow’s depth) 作者: 策略 時(shí)間: 2025-3-27 06:36
https://doi.org/10.1007/978-3-319-44938-8sary for the choice of surgical and medical procedure. The histological report should include a macroscopic and microscopic description of the lesion and the following characteristics: histotype, growth phase, ulceration, number of mitoses, Clark level, tumor-infiltrating lymphocytes, regression, sa作者: myocardium 時(shí)間: 2025-3-27 12:00 作者: 小官 時(shí)間: 2025-3-27 14:33 作者: forecast 時(shí)間: 2025-3-27 20:11 作者: 粗魯性質(zhì) 時(shí)間: 2025-3-27 22:40 作者: 坦白 時(shí)間: 2025-3-28 03:31
https://doi.org/10.1007/978-3-319-45310-1s had lymph node metastases at the time of diagnosis. Randomized clinical trials have supported the therapeutic role of sentinel lymph node biopsy in some subcategories, in particular in intermediate-thickness melanoma. Instead, for thinner and thicker melanoma the role of biopsy is inconsistent or 作者: 恃強(qiáng)凌弱的人 時(shí)間: 2025-3-28 07:01 作者: 令人不快 時(shí)間: 2025-3-28 10:54 作者: Chronic 時(shí)間: 2025-3-28 17:50
Slips of Paper and Performance Artrocedure. Lymph node involvement is diagnosed in different ways, most frequently after sentinel lymph node biopsy (SLNB), but some patients may present clinical evident metastases at diagnosis or during the follow-up. In the case of positive SLNB, about 15–20% of patients have additional metastatic 作者: GROSS 時(shí)間: 2025-3-28 21:50
https://doi.org/10.1007/978-3-319-45772-7mphocele, hematomas and lymphedema. Secondary lymphedema of the limbs is a debilitating and progressive condition that commonly occurs following melanoma treatment. The technique known as lymphatic microsurgical preventive healing approach (LYMPHA) is able to prevent secondary lymphedema following l作者: 殘廢的火焰 時(shí)間: 2025-3-28 23:08 作者: Amplify 時(shí)間: 2025-3-29 06:25
Zheng Liu,Shuting Guo,Tao Li,Wenyan Chen increase in surgical indications also for patients with metastatic melanoma. The surgical indications in this disease setting can be summarized as: collection of biological material; treatment of oligometastatic disease; treatment beyond progression; palliation surgery. In selected cases, surgical 作者: DAMP 時(shí)間: 2025-3-29 10:59
Peizhong Yang,Lihua Zhou,Hongmei Chenith resected, high-risk melanoma. After a 20-year era of adjuvant interferon, checkpoint inhibitor immunotherapy and BRAF+MEK inhibitors revolutionized the management of melanoma in everyday clinical practice. In this review, we summarize the current state of the art of the adjuvant treatment of hig作者: Hay-Fever 時(shí)間: 2025-3-29 13:09 作者: NATAL 時(shí)間: 2025-3-29 16:06 作者: aphasia 時(shí)間: 2025-3-29 22:43 作者: Collected 時(shí)間: 2025-3-30 02:03
Updates in Surgeryhttp://image.papertrans.cn/d/image/241238.jpg作者: 不可思議 時(shí)間: 2025-3-30 06:09 作者: 脆弱帶來(lái) 時(shí)間: 2025-3-30 12:01 作者: vasculitis 時(shí)間: 2025-3-30 15:46
Current Management of Melanoma978-3-030-45347-3Series ISSN 2280-9848 Series E-ISSN 2281-0854 作者: interpose 時(shí)間: 2025-3-30 19:26 作者: 開(kāi)始沒(méi)有 時(shí)間: 2025-3-30 22:01 作者: 性滿足 時(shí)間: 2025-3-31 03:57 作者: emulsify 時(shí)間: 2025-3-31 06:50
Histopathological Examination: The Keystone of Treatment of Melanoma,and the following characteristics: histotype, growth phase, ulceration, number of mitoses, Clark level, tumor-infiltrating lymphocytes, regression, satellitosis, lymphovascular invasion, and neurotropism.作者: Daily-Value 時(shí)間: 2025-3-31 09:25
Molecular Assessment in Patients with Melanoma: When and Why?,tients with advanced or resected high-risk melanoma..In this chapter, we report on the main advantages and disadvantages of the most commonly used diagnostic strategies, and discuss the indications and timing of this molecular assessment in patients with melanoma.作者: 完成 時(shí)間: 2025-3-31 14:56 作者: Customary 時(shí)間: 2025-3-31 20:33 作者: 廣大 時(shí)間: 2025-4-1 01:24 作者: Parallel 時(shí)間: 2025-4-1 02:47 作者: 非實(shí)體 時(shí)間: 2025-4-1 06:28
